Abbott Hits Hospira With Patent Suit Over Zemplar
Abbott Laboratories slapped Hospira Inc. with a lawsuit Thursday in Delaware federal court, claiming that Hospira infringed two patents by trying to tap into the market for paricalcitol, which Abbott markets...To view the full article, register now.
Already a subscriber? Click here to view full article